FDA Investigator David L Chon

David L Chon has conducted inspections on 140 sites in 12 countries as of 24 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
140
Last Inspection Date:
24 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100004090
Countries of Inspections:
Sweden, United States of America, Congo, Germany, Austria, Hungary, Belgium, Korea (Republic of), Taiwan, France, Switzerland, Canada
FDA Investigators that have inspected at least one site in common with David L Chon:
Addie V Scott Boston, Adriana N Jimenez Lopez, Alan C Gion, Amber G Chung, Amy A Johnson, Amy C Amaro, Ana P Barido, Anastasia I Offordile, Andrew J Howard, Andrew R Wasko, Andrew T Todd, Anitha Palamakula Govada, Annabelle Crusan, D,VM, Anne E Johnson, Anthony J Grace, Antoine El Hage, PhD, Arianne L Motter, Arindam Dasgupta, PhD, Austin B Appler, Barbara A Crowl, Barbara J Holladay, Barbara Janine Breithaupt, Barbara T Carmichael, Bei Yu, Billingsley, Braedyn K Kromer, Brandon L Mariner, Brian R Yaun, Brittany L Carpenter, Brooke K Higgins, Bryan J Love, Candice C Mandera, Candice J Cortes, Carrie L Doupnik, Charlean R Butler, Charles A Snipes, PhD, Charles D Boison, Charles E Idjagboro, Charles M Kerns, BLT DO, Charles R Bonapace, PhD, Cheryl A Grandinetti, Chrissy J Cochran, Christine M O'leary, Christine M Whitby, CSO, Christopher M Jeffers, Christopher R Richardson, Christopher R Wells, Clarice J Ahn, Collins, Collins M Mason, Courtney N Long, Craig T Rybus, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, David A Oluwo, David K Glasgow, David P Rice, Jr, Dawn C Olenjack, Debra D Devlieger, Denise R Beuttenmuller, Dennis L Doupnik, Dianne H Milazzo, Dirk L Lincoln, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dung N Tran, Dylan D Yao, MD, PhD, Earl Echon, Ekaterina Allen, Eleanor M Felton, Elizabeth A Laudig, Ellen A Humphrey, Emily A Baldwin, Emmanuel A Dimaano, Jr, Erin L Mcfiren, Erin M Mcdowell, Esaw, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gale L Glinecki, Geoffrey K Kilili, Gerald D Bromley, Jr, Gerald Mierle, Gifford Whitehurst, Jr, Glenn B Mannheim, Heath A Gerber, Hector Jcolon Torres, Helen B Ricalde, Hugh M Mcclure, II, Jacqueline Mdiaz Albertini, James M Simpson, James R Birkenstamm, James T Mccoy, Jamie D Richardson, Janet L Bowen, Janete F Guardia, Jazmine N Brown, Jean M Mulinde, MD, Jeffrey A Reed, Jessica D Nanini, Jessica D Weber, Joey C West, John A Kadavil, PhD, John Dan, John M Gusto, Johnny D Nwankwo, Johnson, Jonathan D Green, Jonathan W Chapman, Joseph L Despins, PhD, Joseph W Matthews, Julie A Silberberg, Justin A Hefferman, Jyoti B Patel, PhD, Kailee R Mason, Karen M Cooper, Katherine D Kim, Kenneth L Smalls, Kenneth Nieves, Kirk A Dymbrowski, La Tasham Gunter, Lakisha M Williams, Lara M Snyder, Laurianne M Montonye, Laurimer Kuilan Torres, LCDR Cornelius Brown, III, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Lee Hong Pai Scherf, Lequita M Mayhew, Li Hongpaul Yeh, PhD, Linda J Eason, Linda S Mattingly, Lori S Lawless, Louis G An, LT Melanie M Mayor, USPHS, Luann Mckinney, Lucilla Facchin, Lynette P Salisbury, Marc A Jackson, Jr, Marcus A Ray, Margaret Torres Vazquez, Marilyn M White, Marla A Cassidy, Matthew R Coleman, Miah Jung, Michael F Skelly, PhD, Michael L Zimmerman, Mihaly S Ligmond, Mildred L Mccray, Mindy M Chou, Mohamad A Chahine, Mohsen Rajabi Abhari, FDA, Monique Rac Lester, Nancy L Meade, Nancy L Neiger, Natasha A Dezinna, Natasha Gupta, Nebil A Oumer, Nichole J Chamberlain, Nutan Mytle, Olumide A Akinyemi, Omotunde O Osunsanmi, Paula J Bretz, Pelekakis, Philip W Beck, Puspa Suresh Jayasekara, Quynh Van Tran, Rachel C Harrington, Randy L Clarida, Raymond L Cheung, Regina Gibson Melton, Renisha M Shaw, Richard J Bashay, Richard W Berning, Rina Bhikha, Robin R Waller, Ronald T Nowalk, Sam H Haidar, PhD, Serajus Salaheen, Sherry L Secrist, BLT DO, Sidney B Priesmeyer, Sierra M Shockley, Slatten, Stacey A Priest, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen C Eason, Stephen D Brown, Steven D Banks, Steven J Thurber, Susan J Essenmacher, Susan M Jackson, Susanne M Richardson, MS RAC, Sylvia R Dooling, Tajah L Blackburn, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Tara K Carmody, Teigan M Mule, Theresa M Smedley, Tiki J Dixon, Timothy K Lee, PhD, Valeria A Moore, Valerie L Kelesyan, Vanessa E Coulter, Veronica L Bush, Wanda Y Honeyblue, Wayne L Jefferson, William D Bassett, Jr, William H Linkroum, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yaharn Su, Yangmin Ning, Young M Yoon, Yvonne T Lacour

David L Chon's Documents

Publish Date Document Type Title
July, 2016 EIR Yvonne Knight - EIR, 2016-07-21
March, 2023 FDA 483 H. Henry Li, MD - Form 483, 2023-03-24
June, 2023 FDA 483 Wayne Farnsworth, MD - Form 483, 2023-06-27
November, 2020 EIR Ira L. Berger, M.D. - EIR, 2020-11-13
December, 2021 FDA 483 Amarex Clinical Research, LLC - Form 483, 2021-12-29
November, 2017 EIR Dp Clinical Inc - EIR, 2017-11-13
March, 2024 FDA 483 Vanda Pharmaceuticals Inc - Form 483, 2024-03-12
June, 2017 EIR Adam F. Lowy, M.D. - EIR, 2017-06-09
November, 2019 FDA 483 Zsolt Szabo, M.D. - Form 483, 2019-11-22
May, 2021 FDA 483 Mark Roschewski, M.D. - Form 483, 2021-05-11
September, 2017 FDA 483 Response Belmora LLC - Form 483R, 2017-09-13
April, 2021 FDA 483 Jeffrey S. Dome, M.D. - Form 483, 2021-04-12
February, 2018 FDA 483 BASi Gaithersburg, LLC - Form 483, 2018-02-21
February, 2016 EIR Augusto D. Pichard, M.D. - EIR, 2016-02-09
February, 2020 FDA 483 U.S. Army Medical Research Institute of Infectious Diseases - Form 483, 2020-02-03
June, 2019 EIR Johns Hopkins University Laboratory - EIR, 2019-06-14
February, 2016 FDA 483 Augusto D. Pichard, M.D. - Form 483, 2016-02-09
August, 2017 FDA 483 William H. Theodore - Form 483, 2017-08-08
August, 2017 FDA 483 Henrys Farm Inc. - Form 483, 2017-08-31
November, 2015 EIR Precision Nuclear of Virginia, LLC - EIR, 2015-11-19
August, 2021 EIR LABCORP DRUG DEVELOPMENT INC. - EIR, 2021-08-31
May, 2023 FDA 483 James A. Simon, MD - Form 483, 2023-05-05
March, 2023 FDA 483 Reveragen Biopharma Inc. - Form 483, 2023-03-06
February, 2018 EIR BASi Gaithersburg, LLC - EIR, 2018-02-21
September, 2017 FDA 483 Belmora LLC - Form 483, 2017-09-13
December, 2017 FDA 483 Manish A. Patel, M.D. - Form 483, 2017-12-15
November, 2016 FDA 483 National Cancer Institute (NCI) - Form 483, 2016-11-15
April, 2017 EIR Suzanne Groah, MD - EIR, 2017-04-04
February, 2021 FDA 483 Benjamin S. Gonzalez, MD - Form 483, 2021-02-03
November, 2015 FDA 483 Response Precision Nuclear of Virginia, LLC - Form 483R, 2015-12-09
November, 2018 EIR Experimental Pathology Laboratories, Inc. - EIR, 2018-11-13
April, 2024 FDA 483 Mark Roschewski, M.D. - Form 483, 2024-04-15
June, 2022 FDA 483 Institute for In Vitro Sciences, Inc. - Form 483, 2022-06-01
August, 2022 FDA 483 National Cancer Institute Central IRB - Form 483, 2022-08-09
May, 2021 EIR Advarra IRB - EIR, 2021-05-27
November, 2022 FDA 483 David L. Scott, MD - Form 483, 2022-11-18
January, 2018 FDA 483 AstraZeneca Pharmaceuticals, LP - Form 483, 2018-01-30
April, 2017 FDA 483 Suzanne Groah, MD - Form 483, 2017-04-04
January, 2018 EIR AstraZeneca Pharmaceuticals, LP - EIR, 2018-01-30
July, 2016 FDA 483 Yvonne Knight - Form 483, 2016-07-21
October, 2022 FDA 483 Robert S. Call, M.D. - Form 483, 2022-10-19
September, 2023 FDA 483 Dr. James A. Thompson, M.D. - Form 483, 2023-09-27
February, 2018 FDA 483 Paolo DePetrillo, MD - Form 483, 2018-02-28
October, 2020 EIR Ozlem Goker-Alpan, MD - EIR, 2020-11-25
May, 2024 FDA 483 Medstar Cardiovascular Research Network - Form 483, 2024-05-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more